SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-17-195948
Filing Date
2017-06-06
Accepted
2017-06-06 16:06:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d311440d424b5.htm 424B5 280034
2 GRAPHIC g311440g77z72.jpg GRAPHIC 24358
3 GRAPHIC g311440g89r58.jpg GRAPHIC 47764
  Complete submission text file 0001193125-17-195948.txt   380729
Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-217573 | Film No.: 17894214
SIC: 2834 Pharmaceutical Preparations